ORYZON reports results and corporate update for quarter ended March 31, 2021 10/05/2021 Healthcare La compañía invierte 3,6 M€ en I+D sin impactos significativos derivados de la pandemia covid-19 Partners - Oryzon Genomics
3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new t... 06/05/2021 Healthcare Innovative drugs Advanced therapies BioSpain 3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the... Partners - 3PBIOVIAN
Ysios Capital leads a 51 million euros investment in Adcendo 29/04/2021 Healthcare Financing Adcendo (Copenhagen, Denmark), is a biotechnology company specializing in the development of immunoconjugated drugs for... Partners - Ysios Capital Partners
Spain leads research in advanced therapies with almost 120 clinical trials 07/04/2021 Spain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of... AseBio
Proteos Biotech inaugurates new pharmaceutical plant in Barcelona 20/04/2021 Healthcare This project will enable it to expand and improve its CMO services, supporting customers in the manufacture of sterile... Partners
QualitecFarma starts clinical operations from its headquarters in USA 20/04/2021 Healthcare The company is dedicated to providing international support to the pharmaceutical and biotechnology industry in the... Partners
BCN HEALTH has published 14 studies in 2020 assessing the incidence and costs of illness o... 20/04/2021 Healthcare The company conducted retrospective studies based on records of patients diagnosed with the different diseases and... Partners
Advanced Therapies Congress & Expo Londres Inglaterra Del 05/10/2021 to 06/10/2021 Healthcare Advanced therapies
Biotechnology innovations for the cosmetic industry On-line Del 24/03/2021 16:00 to 24/03/2021 16:00 Healthcare
